Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_assertion type Assertion NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_head.
- NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_assertion description "[Cyclooxygenase-2 (COX-2) overexpression is a widely recognized feature of human breast cancer and inhibitors of the enzyme have antitumor effects in a subset of tumor settings.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_provenance.
- NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_assertion evidence source_evidence_literature NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_provenance.
- NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_assertion SIO_000772 15967164 NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_provenance.
- NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_assertion wasDerivedFrom befree-2016 NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_provenance.
- NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_assertion wasGeneratedBy ECO_0000203 NP500267.RAV6Bpx6QMey6U6NX5kFKSs-IUrtAxwcrX6Zk_02QSets130_provenance.